Skip to main content
. Author manuscript; available in PMC: 2020 Jun 10.
Published in final edited form as: Semin Cancer Biol. 2017 Dec 15;51:36–49. doi: 10.1016/j.semcancer.2017.12.004

Fig. 1.

Fig. 1.

Potential non-or minimally-invasive DNA methylation biomarkers for the detection of different gastrointestinal cancers. FDA approved markers are marked in bold, validated markers or markers that are reported to be frequently methylated in larger non-invasive patients series are in normal typing. Smaller sample series have been analyzed for CCA, esophageal-, HCC and pancreatic- cancer compared to colorectal and gastric cancer. Abbreviations: CCA, cholangiocarcinoma; HCC, hepatocellular carcinoma.